A Study to Evaluate the Efficacy and Safety of CAEL-101 in Patients With Mayo Stage IIIa AL Amyloidosis (CARES)
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc.
Kedrion S.p.A.
Life Molecular Imaging SA
SWOG Cancer Research Network
Prothena Biosciences Ltd.
Air Force Military Medical University, China
National Cancer Institute (NCI)
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Case Comprehensive Cancer Center
Canadian Cancer Trials Group
Boston Medical Center
European Myeloma Network B.V.
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Mayo Clinic
INSYS Therapeutics Inc
Nanjing University School of Medicine
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
European Organisation for Research and Treatment of Cancer - EORTC
Vanderbilt-Ingram Cancer Center
Northwestern University
Mayo Clinic
National Cancer Institute (NCI)
University Hospital, Limoges